US President Donald Trump is reportedly considering linking prescription drug prices to their price tags in other developed nations.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Bribe locally, fundraise globally. That pretty much sums up the business ethos of billionaire Gautam Adani as laid out by US prosecutors.
The House of Mouse hopes to double the size of its leisure fleet by 2031 in an “unprecedented period of growth.”
Military tech startups are seeing a big boost in their valuations of late, spurred in part by former President Trump’s re-election.
Three titans of the US defense industry — Lockheed Martin, RTX, and Northrop Grumman — signalled tariffs are going to be bad for business.
Will generative artificial intelligence’s star be added to the Hollywood Walk of Fame? Andreessen Horowitz sure thinks so.
Budget-friendly Spirit Airlines hasn’t reported an annual profit since 2019, and has lost some $2.2 billion since 2020.
The Trump White House may usher in a big loosening of the rules around cars that can operate without human drivers.
A half dozen humanoid robots completed a half marathon in Beijing, though their prowess still trails human runners by a considerable amount.
Snacking conglomerates all agree: Petcare mergers and acquisitions are the cat’s pajamas. Just ask General Mills.
Has Bob Iger now done it? Has he restored the magic, the thing defeated activist agitator Carl Icahn said was missing?
Charging infrastructure remains a barrier in EV adoption.
The technology is garnering interest for its energy-saving benefits.
While Kuiper won’t generate revenue for a while, Amazon is still using its enormous influence to position itself for some corporate Star Wars.
It seems quality never goes out of style for Levi Strauss, even amid a a tariff-induced global financial meltdown.
Airline stocks are in a prolonged nosedive: Delta, American, and United have each fallen 35 to 45% this year.